Best innovation in integrated commissioning, or integrated care, model

This category is aimed at commissioners, clinicians or organisations that have developed innovative integrated models putting users at the centre of pathway redesign and bringing together services to improve patient care. Applications from teams and/or commissioners working across organisational boundaries, where patient care can move seamlessly between services will be encouraged. Entries will be considered from initiatives that have facilitated new or improved services in diabetes care at any point along the patient pathway including prevention.

Entries must demonstrate evidence of the following:

  • A clearly identified problem(s) with coherent aims, objectives, a documented programme of care with timescales, evidence of outcomes and follow-up data
  • Involvement of stakeholders and/or people with diabetes in developing the initiative
  • Evidence of quality improvement in the six dimensions of quality improvement; ie there should be evidence of safety, effectiveness, efficiency (including cost savings) as well as being patient-centred, equitable and timely. There should be reference to cost savings/cost-effectiveness.
  • Sustainability
  • User stories.

Evidence should also be shown of:

  • User involvement in service design and evaluation
  • Transferability to other areas/organisations/departments and sectors
  • Impact on staff and/or the organisation
  • Innovation.





Debbie Tuesley
+44 (0)1372 414243

Siobhan Thwaites
+44 (0)1372 414247

The Diabetes Times


Using a patient specific protocol to improve the emergency management of suspected febrile neutropenia/neutropenic sepsis in patients on systemic anti-cancer chemotherapy

Neutropenic sepsis/febrile neutropenia (NS/FN) is a potentially fatal complication of chemotherapy. National guidance recommends that the first dose of antibiotics should be given within 60... continue reading